Rating History for Onconova Therapeutics (ONTX) by H.C. Wainwright
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/21/2023 | Joseph Pantginis | Upgrade | Buy (N/A) |
11.00 (N/A) |
0.70 (13.13) |
1775.71% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/21/2023 | Joseph Pantginis | Upgrade | Buy (N/A) |
11.00 (N/A) |
0.70 (13.13) |
1775.71% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||